Physician profile
Suzin Cho
NPI 1093798480
$491.62
in general payments reported to CMS, 2019-2025
12 companies · $65.30 in 2025
The $65.30 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $96.51 · 2021: $12.64 · 2022: $90.01 · 2023: $50.07 · 2024: $52.69 · 2025: $65.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $114.28 | 2019-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Becton, Dickinson and Company | $57.25 | 2020 | |
| Roche Diagnostics Corporation | $48.65 | 2019 | |
| Organon LLC | $43.63 | 2022 | |
| Exact Sciences Corporation | $40.81 | 2023-2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $35.44 | 2019 | |
| Pfizer INC. | $35.16 | 2023-2025 | |
| Axonics, INC. | $30.26 | 2022-2024 | Axonics |
| Therapeuticsmd, INC. | $28.56 | 2019-2020 | |
| Exeltis, USA INC. | $27.47 | 2021-2023 | Slynd |
| Sage Therapeutics, LLC | $17.44 | 2024 | |
| Abbvie INC. | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzin Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.